- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Rear Admiral Dr Wanda Barfield on Perinatal Morbidity and Mortality
Rear Admiral Wanda Barfield, MD, MPH, director of the Division of Reproductive Health for the CDC, discusses how the CDC is working to counteract perinatal morbidity and mortality in the United States.
Rear Admiral Wanda Barfield, MD, MPH, director of the Division of Reproductive Health for the CDC, discusses how the CDC is working to counteract perinatal morbidity and mortality in the United States.
Transcript:
What has your research shown about perinatal morbidity and mortality specifically in the United States, and what is being done to address it?
So, what we understand is 1, we're seeing that women are aging with time in terms of their first birth. We're also seeing that women are experiencing increasing rates of chronic disease such as diabetes, hypertension disorders, obesity, and mental health issues. That has consequences for not only the mother, not only during pregnancy but beyond pregnancy.
And of course there are also consequences to her baby. What we're seeing with [Centers for Disease Control and Prevention, CDC] is the importance to address chronic disease prevention in women of reproductive age. We really want to move upstream in terms of looking at the preconception health period, as well as the period between pregnancies and after pregnancies as women age onto adulthood.
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Finding the Right Biomarker Is Key to the TIGIT Puzzle, Experts Say
May 12th 2025Data for SKYSCRAPER-01, involving the anti-TIGIT antibody tiragolumab, align with recent bad news for this once-promising therapeutic target. But investigators involved in TIGIT studies say the problem is finding the right biomarker.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Addressing KRAS Resistance, RAS(ON) Therapies Find Limelight at AACR
May 5th 2025KRAS-targeted therapies, including daraxonrasib and zoldonrasib, show promise in overcoming resistance in cancer treatment, as highlighted at the 2025 meeting of the American Association for Cancer Research (AACR).
Read More
